During the last three months, 13 analysts shared their evaluations of Celanese (NYSE:CE), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 6 | 5 | 2 | 0 |
| Last 30D | 0 | 0 | 1 | 1 | 0 |
| 1M Ago | 0 | 2 | 1 | 0 | 0 |
| 2M Ago | 0 | 2 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 2 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $171.08, a high estimate of $195.00, and a low estimate of $144.00. Witnessing a positive shift, the current average has risen by 5.01% from the previous average price target of $162.92.
Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light on the perception of Celanese by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Begleiter | Deutsche Bank | Lowers | Hold | $160.00 | $175.00 |
| Steve Byrne | B of A Securities | Lowers | Underperform | $144.00 | $147.00 |
| Charles Neivert | Piper Sandler | Raises | Overweight | $180.00 | $170.00 |
| John McNulty | BMO Capital | Raises | Market Perform | $158.00 | $153.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $176.00 | $171.00 |
| Ghansham Panjabi | Baird | Raises | Outperform | $180.00 | $165.00 |
| Kieran De Brun | Mizuho | Raises | Neutral | $173.00 | $161.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $171.00 | $165.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $167.00 | $150.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $190.00 | $176.00 |
| Michael Leithead | Barclays | Maintains | Equal-Weight | $170.00 | $170.00 |
| Jeffrey Zekauskas | JP Morgan | Raises | Underweight | $160.00 | $135.00 |
| Michael Sison | Wells Fargo | Raises | Overweight | $195.00 | $180.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Celanese. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Celanese compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Celanese's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Celanese's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Celanese analyst ratings.
About Celanese
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Financial Milestones: Celanese's Journey
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Negative Revenue Trend: Examining Celanese's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -8.48% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.63%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Celanese's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.71%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.46%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Celanese's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.96, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
What Are Analyst Ratings?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.